<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H21C1B7F3E9A44207A741DF481A352E61" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 679 IH: Effective Drug Control Strategy Act of 2021</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2021-02-01</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 679</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20210201">February 1, 2021</action-date><action-desc><sponsor name-id="T000483">Mr. Trone</sponsor> (for himself and <cosponsor name-id="B001309">Mr. Burchett</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HGO00">Committee on Oversight and Reform</committee-name>, and in addition to the Committee on <committee-name committee-id="HIF00">Energy and Commerce</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Office of National Drug Control Policy Reauthorization Act of 1998 to direct the Office of National Drug Control Policy to publish a list of drug control grant programs, and for other purposes.</official-title></form><legis-body id="H9896455F46EB4E748A001AC529A18824" style="OLC"><section id="H3A3172A893004C3182E1F1B240C41B06" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Effective Drug Control Strategy Act of 2021</short-title></quote>.</text></section><section id="H6E9589B14BFD42AFB38F062FBC3E26BF" section-type="subsequent-section"><enum>2.</enum><header>Federal drug demand reduction activities</header><subsection id="H99E9BF31C31144C9AEE296911425393D"><enum>(a)</enum><header>Publication of list</header><paragraph id="H8145BC904084403F8D9DF95A0447EAB9"><enum>(1)</enum><header>Amendment</header><text display-inline="yes-display-inline">Section 705(f) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1704">21 U.S.C. 1704(f)</external-xref>) is amended by inserting at the end the following new paragraph:</text><quoted-block display-inline="no-display-inline" id="HEB0D66D1B3514CDB93EEEA268FC90F54" style="OLC"><paragraph id="H92B0223F475A4D42BC96E2F07A729A67"><enum>(5)</enum><header>Publication of list</header><text display-inline="yes-display-inline">The Director shall publish online a complete list of all drug control program grant programs and any other relevant information included in the information tracked pursuant to paragraph (1).</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph><paragraph id="H01796960C3024A79B44061BAC713B635"><enum>(2)</enum><header>Deadline and frequency</header><text display-inline="yes-display-inline">Not later than one year after the date of the enactment of this Act, and annually thereafter, the Director of National Drug Control Policy shall publish the list required under section 705(f)(5) of the National Drug Control Act of 1998, as added by paragraph (1).</text></paragraph></subsection><subsection id="HD5C4E7A694344B018D16E132C2C684AB"><enum>(b)</enum><header>National Drug Control Strategy</header><text display-inline="yes-display-inline">Section 706(c)(1) of the Office of National Drug Control Policy Reauthorization Act of 1998 (<external-xref legal-doc="usc" parsable-cite="usc/21/1705">21 U.S.C. 1705(c)(1)</external-xref>) is amended by adding at the end the following new subparagraph:</text><quoted-block display-inline="no-display-inline" id="HADD1929D110E485DABBB1F74B747CE43" style="OLC"><subparagraph id="H575D6841CE3544CCA87F4B2A0415E125"><enum>(O)</enum><text display-inline="yes-display-inline">A review of all federally funded demand reduction activities, including an evaluation of—</text><clause id="HD2EB5B2E14AA40888A68C6EEA538298C"><enum>(i)</enum><text>the effectiveness of those activities;</text></clause><clause id="HC81A3F4AF6894B6387A5EA2951F0F31E"><enum>(ii)</enum><text>the contribution of those activities to demand reduction activities funded by State, local, and Tribal governments; and</text></clause><clause id="HC3CFA0294CE54F73A8CCDA69FF4AD4BA"><enum>(iii)</enum><text>whether any duplication or inefficiency in federally funded demand reduction activities needs to be addressed.</text></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section></legis-body></bill> 

